These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
386 related articles for article (PubMed ID: 22986269)
1. Staphylococcus aureus persisters tolerant to bactericidal antibiotics. Lechner S; Lewis K; Bertram R J Mol Microbiol Biotechnol; 2012; 22(4):235-44. PubMed ID: 22986269 [TBL] [Abstract][Full Text] [Related]
2. Interplay between population dynamics and drug tolerance of Staphylococcus aureus persister cells. Lechner S; Patra P; Klumpp S; Bertram R J Mol Microbiol Biotechnol; 2012; 22(6):381-91. PubMed ID: 23363876 [TBL] [Abstract][Full Text] [Related]
3. Daptomycin pharmacodynamics against Staphylococcus aureus hemB mutants displaying the small colony variant phenotype. Begic D; von Eiff C; Tsuji BT J Antimicrob Chemother; 2009 May; 63(5):977-81. PubMed ID: 19304733 [TBL] [Abstract][Full Text] [Related]
4. Glucose Augments Killing Efficiency of Daptomycin Challenged Staphylococcus aureus Persisters. Prax M; Mechler L; Weidenmaier C; Bertram R PLoS One; 2016; 11(3):e0150907. PubMed ID: 26960193 [TBL] [Abstract][Full Text] [Related]
5. Antibiotic Tolerance in Biofilm and Stationary-Phase Planktonic Cells of Kamble E; Pardesi K Microb Drug Resist; 2021 Jan; 27(1):3-12. PubMed ID: 32013708 [TBL] [Abstract][Full Text] [Related]
6. Extracellular and intracellular bactericidal activities of XF-70 against small-colony variant hemB mutants of meticillin-susceptible and meticillin-resistant Staphylococcus aureus. Vaudaux P; Huggler E; Rhys-Williams W; Love WG; Lew DP Int J Antimicrob Agents; 2011 Jun; 37(6):576-9. PubMed ID: 21414759 [TBL] [Abstract][Full Text] [Related]
7. High persister cell formation by clinical Liu L; Wang Y; Bojer MS; Andersen PS; Ingmer H Microbiology (Reading); 2020 Jul; 166(7):654-658. PubMed ID: 32427093 [TBL] [Abstract][Full Text] [Related]
8. Role of persisters and small-colony variants in antibiotic resistance of planktonic and biofilm-associated Staphylococcus aureus: an in vitro study. Singh R; Ray P; Das A; Sharma M J Med Microbiol; 2009 Aug; 58(Pt 8):1067-1073. PubMed ID: 19528167 [TBL] [Abstract][Full Text] [Related]
9. Persister formation in Staphylococcus aureus is associated with ATP depletion. Conlon BP; Rowe SE; Gandt AB; Nuxoll AS; Donegan NP; Zalis EA; Clair G; Adkins JN; Cheung AL; Lewis K Nat Microbiol; 2016 Apr; 1():16051. PubMed ID: 27572649 [TBL] [Abstract][Full Text] [Related]
10. 5-Methylindole Potentiates Aminoglycoside Against Gram-Positive Bacteria Including Sun F; Bian M; Li Z; Lv B; Gao Y; Wang Y; Fu X Front Cell Infect Microbiol; 2020; 10():84. PubMed ID: 32185144 [TBL] [Abstract][Full Text] [Related]
11. Prophages and Growth Dynamics Confound Experimental Results with Antibiotic-Tolerant Persister Cells. Harms A; Fino C; Sørensen MA; Semsey S; Gerdes K mBio; 2017 Dec; 8(6):. PubMed ID: 29233898 [TBL] [Abstract][Full Text] [Related]
12. Borrelia burgdorferi, the Causative Agent of Lyme Disease, Forms Drug-Tolerant Persister Cells. Sharma B; Brown AV; Matluck NE; Hu LT; Lewis K Antimicrob Agents Chemother; 2015 Aug; 59(8):4616-24. PubMed ID: 26014929 [TBL] [Abstract][Full Text] [Related]
13. A high-throughput assay identifies molecules with antimicrobial activity against persister cells. Petersen ME; Hansen LK; Mitkin AA; Kelly NM; Wood TK; Jørgensen NP; Østergaard LJ; Meyer RL J Med Microbiol; 2024 Jul; 73(7):. PubMed ID: 38995832 [No Abstract] [Full Text] [Related]
14. Persister cells and tolerance to antimicrobials. Keren I; Kaldalu N; Spoering A; Wang Y; Lewis K FEMS Microbiol Lett; 2004 Jan; 230(1):13-8. PubMed ID: 14734160 [TBL] [Abstract][Full Text] [Related]
15. Metabolic and transcriptional activities of Staphylococcus aureus challenged with high-doses of daptomycin. Lechner S; Prax M; Lange B; Huber C; Eisenreich W; Herbig A; Nieselt K; Bertram R Int J Med Microbiol; 2014 Nov; 304(8):931-40. PubMed ID: 24980509 [TBL] [Abstract][Full Text] [Related]
16. Starvation- and antibiotics-induced formation of persister cells in Pseudomonas aeruginosa. Mlynarcik P; Kolar M Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Mar; 161(1):58-67. PubMed ID: 27886280 [TBL] [Abstract][Full Text] [Related]
17. Antimicrobial activity of daptomycin tested against Staphylococcus aureus with vancomycin MIC of 2 microg/mL isolated in the United States and European hospitals (2006-2008). Sader HS; Becker HK; Moet GJ; Jones RN Diagn Microbiol Infect Dis; 2010 Mar; 66(3):329-31. PubMed ID: 20159377 [TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic evaluation of the activity of antibiotics against hemin- and menadione-dependent small-colony variants of Staphylococcus aureus in models of extracellular (broth) and intracellular (THP-1 monocytes) infections. Garcia LG; Lemaire S; Kahl BC; Becker K; Proctor RA; Denis O; Tulkens PM; Van Bambeke F Antimicrob Agents Chemother; 2012 Jul; 56(7):3700-11. PubMed ID: 22564838 [TBL] [Abstract][Full Text] [Related]
19. Survival of bactericidal antibiotic treatment by tolerant persister cells of Klebsiella pneumoniae. Li Y; Zhang L; Zhou Y; Zhang Z; Zhang X J Med Microbiol; 2018 Mar; 67(3):273-281. PubMed ID: 29458540 [TBL] [Abstract][Full Text] [Related]
20. Bactericidal activity of daptomycin versus vancomycin in the presence of human albumin against vancomycin-susceptible but tolerant methicillin-resistant Staphylococcus aureus (MRSA) with daptomycin minimum inhibitory concentrations of 1-2microg/mL. Torrico M; Giménez MJ; González N; Alou L; Sevillano D; Cafini F; Prieto J; Cleeland R; Aguilar L Int J Antimicrob Agents; 2010 Feb; 35(2):131-7. PubMed ID: 20006469 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]